Surgery showdown: can debulking beat drugs for pancreatic cancer?
NCT ID NCT07273409
First seen Jan 11, 2026 · Last updated Jun 09, 2026 · Updated 21 times
Summary
This study looks at people with stage 4 pancreatic neuroendocrine tumors (pan-NET) that have spread. It compares two approaches: having surgery to remove as much tumor as possible (plus optional drug treatment) versus drug treatment alone. The goal is to see which helps people live longer and have a better quality of life. About 200 adults with grade 1-2 pan-NET will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karolinska University Hospital
RECRUITINGStockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skåne University Hospital
NOT_YET_RECRUITINGLund, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Uppsala University Hospital
RECRUITINGUppsala, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.